BrainStorm Cell Therapeutics
BCLI
#10103
Rank
HK$56.66 M
Marketcap
HK$8.69
Share price
14.87%
Change (1 day)
-86.30%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -HK$4.63

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$4.58. In 2022 the company made an earnings per share (EPS) of -HK$5.12 an increase over its 2021 EPS that were of -HK$5.27.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.63-9.65%
2022-HK$5.12-2.94%
2021-HK$5.27-37.04%
2020-HK$8.381.89%
2019-HK$8.2251.43%
2018-HK$5.43159.26%
2017-HK$2.09-3.57%
2016-HK$2.17-37.78%
2015-HK$3.49-33.82%
2014-HK$5.2736%
2013-HK$3.8811.11%
2012-HK$3.4950%
2011-HK$2.33-50%
2010-HK$4.65-233.33%
2009HK$3.49-142.86%
2008-HK$8.14-65%
2007-HK$23.27
2005HK$7.68-108.03%
2004-HK$95.6713203.07%
2003-HK$0.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$34.05-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$44.13 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$31.10 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.18-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.59 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA